Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
Insider trades, last 90 days
0 buys · 5 sells
- Sold $4.67M
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
219
- −10 vs. Q1 2026
- Total value $3.34B
Superinvestors holding VERA
0
- None of the superinvestors held VERA at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by VERA insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 20264:28 PM ET | Sep 15, 2026 | Fordyce MarshallPRESIDENT AND CEO | SSaleClass A Common Stock | −18.5K | $37.00 | −$684.5K | 235.24K | −7.3% | SEC10b5-1 |
| Sep 4, 20264:15 PM ET | Sep 2, 2026 | Fordyce MarshallPRESIDENT AND CEO | SSaleClass A Common Stock | −18.5K | $35.1158 | −$649.64K | 235.24K | −7.3% | SEC10b5-1 |
| Aug 12, 20266:42 PM ETAmended | Jul 7, 2026 | Fordyce MarshallPRESIDENT AND CEO | SSaleClass A Common Stock | −46.25K | $42.2959 | −$1.96M | 235.24K | −16.4% | SEC10b5-1 |
| Aug 12, 20266:41 PM ETAmended | Jun 23, 2026 | Fordyce MarshallPRESIDENT AND CEO | SSaleClass A Common Stock | −18.5K | $37.9335 | −$701.77K | 235.24K | −7.3% | SEC10b5-1 |
| Aug 12, 20266:39 PM ETAmended | May 12, 2026 | Fordyce MarshallPRESIDENT AND CEO | SSaleClass A Common Stock | −18.5K | $36.7431 | −$679.75K | 235.24K | −7.3% | SEC10b5-1 |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in VERA at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,747,760 | $246.64M | 0.00% | +659,658+13.0% | Added |
| Avoro Capital Advisors LLC | 5,723,888 | $245.61M | 2.21% | −165,000−2.8% | Reduced |
| STATE STREET CORP | 4,148,786 | $178.02M | 0.01% | +785,148+23.3% | Added |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4,012,936 | $172.2M | 0.02% | −561,094−12.3% | Reduced |
| Deep Track Capital, LP | 4,000,000 | $171.64M | 2.53% | −106,067−2.6% | Reduced |